EAM Investors’s Genomic Health, Inc. GHDX Stock Holding History

EAM Investors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14,738	Closed	-$1.03M	–	338
2019 Q1	$1.03M	Sell	14,738 -13,336	-48%	-$989K	0.25%	185
2018 Q4	$1.81M	Sell	28,074 -19,456	-41%	-$1.36M	0.49%	62
2018 Q3	$3.34M	Sell	47,530 -22,463	-32%	-$1.31M	0.5%	75
2018 Q2	$3.53M	Buy	+69,993	New	+$2.78M	0.56%	45
2016 Q1	–	Sell	-29,970	Closed	-$1.05M	–	376
2015 Q4	$1.05M	Buy	+29,970	New	+$803K	0.14%	268

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EAM Investors's GHDX Position: Q2 2019 in Review

EAM Investors sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 14,738 shares — an estimated $1.03M sold.

EAM Investors first reported a position in GHDX in Q4 2015 and held it in 5 quarters. The position peaked at $3.53M in Q2 2018. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

EAM Investors reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
EAM Investors sold 14,738 Genomic Health, Inc. shares in Q2 2019, an estimated $1.03M.
EAM Investors first reported a position in Genomic Health, Inc. in Q4 2015 and held it in 5 quarters.
EAM Investors's Genomic Health, Inc. position peaked at $3.53M in Q2 2018.
215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on EAM Investors's 13F filing for Q2 2019, filed 14 Aug 2019.